Improving Care of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)


Female doctor consulting senior male patient both looking at ipadParticipation in activities of daily life can be challenging for those with transthyretin amyloid cardiomyopathy (ATTR-CM), a restrictive cardiomyopathy produced by extracellular deposition of transthyretin. Geographic and racial healthcare disparities add to the burden of disease. Shared decision making and early detection with readily available noninvasive tests, among other strategies, are essential as therapy for ATTR-CM.

Live Webinar

Developing an Amyloidosis Center of Excellence: Path to Success and Overcoming Challenges

October 25, 2022, 1:00 pm CT

This live webinar discusses steps to develop a center of excellence to provide leadership, best practices, support and/or training of HCPs within a multidisciplinary team environment to improve the quality of care for cardiac amyloidosis patients as well as challenges that may occur.

Moderator: Katherine E. Di Palo, PharmD, FAHA, BCACP, BCGP

Panelists: Jose Nativi Nicolau, MD, MS, FAAC, FHFSA and Johana Fajardo, DNP

CE and MOC Credits Available. Approved for 1.0 AAFP Prescribed Credit.

Videos On Demand

Breaking Down Barriers: Defining and Addressing Healthcare Disparities in ATTR-CM

This is the second webinar in the series. ATTR-CM disproportionately affects black people, a medically underserved population. In this webinar clinicians explore how addressing geographic and racial healthcare disparities can make meaningful differences. Hypertension and other symptoms may confound accurate, timely diagnosis and treatment for many individuals with ATTR-CM. Watch S. Carolina Masri, Kevin Alexander and Nancy Albert discuss practical steps clinicians can take in breaking down barriers for those with ATTR-CM. CE and MOC Credits Available. Approved for 1.0 AAFP Prescribed Credit. Free Webinar.

Empowering Your Patients to Understand ATTR-CM

In this first of a 3-part series, watch Nancy M. Albert and Katherine E. Di Palo join moderator Kevin Alexander in discussing ways to empower patients to recognize ATTR-CM and share in decision-making about diagnostic and treatment options. CE/ABIM MOC credit available. Approved for 1.0 AAFP Prescribed/Elective credits. Free webinar.

Recognize the Complexities of Transthyretin Amyloidosis (ATTR amyloidosis)

The clinical presentation of ATTR may be hidden in plain sight. In these continuing education activities explore the varied clinical presentations of amyloidosis in different organ systems including the heart, nervous system, gastro-intestinal tract, and kidneys. Get the facts from an expert panel on how to recognize and treat the complexities of this progressive, degenerative, and multisystemic disorder.